Distribution & Logistics

Wholesale distributors, 3PLs, and cold-chain logistics providers — maintaining product integrity, traceability, and Good Distribution Practice from release to point of use.

What this page does not claim

A sector is an organization’s role in the value chain, not a legal category. SPEQ maps the disciplines and standards that role typically operates under; it does not determine which apply to your organization, and a count of decoded standards measures SPEQ’s coverage.

WHAT THIS SECTOR DOES

Wholesale distributors, third-party logistics providers (3PLs), and cold-chain specialists move product from the point of manufacture to the point of use without compromising its quality. They hold, transport, and trace medicines and devices — maintaining temperature, security, and an unbroken record of custody so that what reaches the patient is what the manufacturer released.

REGULATORY LANDSCAPE

Distribution follows Good Distribution Practice — the EU GDP Guidelines (2013/C 343/01), WHO TRS 957 Annex 5, and MHRA GDP — plus, in the United States, the Drug Supply Chain Security Act (DSCSA) for traceability. Cold-chain integrity is judged against labelled storage conditions using mean kinetic temperature, and the responsible-person model governs the licensed operation.

THE OVERSIGHT MODEL

The manufacturer/MAH sets the storage and transport conditions and qualifies its distributors; the distributor operates to GDP under a designated Responsible Person and is accountable for maintaining product integrity while it holds custody. Quality/technical agreements define temperature limits, excursion handling, and returns — and every handoff must preserve the traceability chain.

WHAT QUALITY MEANS HERE

01

Cold-chain & temperature control

Qualified storage and shipping lanes, continuous monitoring, and mean-kinetic-temperature assessment of excursions against the labelled condition.

02

Traceability & serialization (DSCSA)

Transaction information and product identifiers that let any unit be traced through the supply chain and suspect or illegitimate product to be quarantined.

03

Falsified-medicine & security controls

Verification, secure custody, and returns handling that keep falsified or diverted product out of the legitimate supply chain.

04

The Responsible Person model

A named, qualified Responsible Person accountable for the GDP operation, licensing, and release of product for onward distribution.

42
Standards decoded
2
GxP disciplines

STANDARDS SPEQ DECODES · 42

Open the full library →
21 CFR Part 820FDAHIGH INSPECTION RISK
Quality Management System Regulation (QMSR) — 21 CFR Part 820
ICH Q9(R1)ICH
Quality Risk Management
ICH Q10ICH
Pharmaceutical Quality System
ISO 9001:2015ISO
Quality Management Systems — Requirements
ISO 13485:2016ISO
Medical Devices — Quality Management Systems — Requirements for Regulatory Purposes
2013/C 343/01ECHIGH INSPECTION RISK
EU Guidelines on Good Distribution Practice of Medicinal Products
WHO TRS 957, Annex 5WHO
WHO Good Distribution Practices for Pharmaceutical Products
MHRA GDPMHRA
UK Good Distribution Practice (Rules & Guidance for Distributors)
MHLW Ordinance No. 136MHLW
Japan GQP — Quality Management for Marketing Authorisation Holders
NOM-059-SSA1-2015COFEPRIS
Mexican Good Manufacturing Practices for Medicines
C.R.C., c. 870, Part C, Div. 2Health CanadaHIGH INSPECTION RISK
Food and Drug Regulations — Part C, Division 2: Good Manufacturing Practices
ISO 14971:2019ISO
Medical Devices — Application of Risk Management to Medical Devices
ISO 22000:2018ISO
Food safety management systems — Requirements for any organization in the food chain
Regulation (EU) 2017/745ECHIGH INSPECTION RISK
Medical Device Regulation (MDR)
21 CFR Part 1, Subpart LFDA
Foreign Supplier Verification Programs (FSVP)
MoCRA (FD&C Act Ch. VI)FDA
Modernization of Cosmetics Regulation Act of 2022
Regulation (EC) No 1223/2009EC
EU Cosmetic Products Regulation
DSCSA (FD&C Act §§581–585)FDAHIGH INSPECTION RISK
Drug Supply Chain Security Act
GS1 General SpecificationsGS1
GS1 General Specifications — identification keys, data attributes and barcodes
EU GMP Annex 21EMAHIGH INSPECTION RISK
Importation of Medicinal Products
ISO 10993-1:2018ISOHIGH INSPECTION RISK
Biological Evaluation of Medical Devices — Part 1: Evaluation and Testing Within a Risk Management Process
Thai FDA GMDP / GMP ClearanceThai FDA
Thai Drug Facility Licensing and Good Manufacturing and Distribution Practice
Del. Reg. (EU) 2016/161ECHIGH INSPECTION RISK
Safety Features on the Packaging of Medicinal Products (Falsified Medicines Directive)
2015/C 95/01EC
EU Guidelines on Good Distribution Practice of Active Substances for Medicinal Products for Human Use
USP <1079>USP
Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products
WHO TRS 961, Annex 9WHO
Model Guidance for the Storage and Transport of Time- and Temperature-Sensitive Pharmaceutical Products
Impl. Reg. (EU) 2021/1280EC
Good Distribution Practice for Active Substances Used as Starting Materials in Veterinary Medicinal Products
PDA TR No. 39PDA
Guidance for Temperature-Controlled Medicinal Products: Maintaining the Quality of Temperature-Sensitive Medicinal Products through the Transportation Environment
Regulation (EU) 2017/746ECHIGH INSPECTION RISK
In Vitro Diagnostic Medical Devices Regulation (IVDR)
21 CFR Part 830FDA
Unique Device Identification
21 CFR Part 806FDAHIGH INSPECTION RISK
Medical Devices; Reports of Corrections and Removals
ISO 19011:2018ISO
Guidelines for Auditing Management Systems
ISO/IEC 27001:2022ISO
Information Security, Cybersecurity and Privacy Protection — Information Security Management Systems — Requirements
21 CFR Part 3FDA
Product Jurisdiction
21 CFR Part 202FDA
Prescription Drug Advertising
ICH M4(R4)ICH
Organisation of the Common Technical Document for the Registration of Pharmaceuticals for Human Use
Directive 2001/83/ECEC
Community Code Relating to Medicinal Products for Human Use
Regulation (EU) 2016/679EC
General Data Protection Regulation (GDPR)
ISO 22301:2019ISO
Security and Resilience — Business Continuity Management Systems — Requirements
ISO 31000:2018ISO
Risk Management — Guidelines
ISO 45001:2018ISO
Occupational Health and Safety Management Systems — Requirements with Guidance for Use
ISO 14001:2015ISO
Environmental Management Systems — Requirements with Guidance for Use

WHERE QUALITY FAILS

  • Temperature excursions in storage or transit with no MKT-based disposition
  • Broken traceability that prevents recall or suspect-product quarantine
  • Falsified or diverted product entering through weak verification and returns controls
  • Distributing without an effective, qualified Responsible Person

KEY REGULATORY BODIES

Derived from the 42 standards SPEQ decodes for this sector.

Distribution & Logistics: frequently asked questions

Reference answers on what a distribution & logistics does, what governs it, and who is accountable for quality.

What is Good Distribution Practice (GDP)?

Good Distribution Practice is the quality standard for the storage, transport, and handling of medicines through the supply chain. It is set out in the EU GDP Guidelines (2013/C 343/01), WHO TRS 957 Annex 5, and MHRA GDP. It ensures product quality, temperature control, security, and traceability are maintained from the point of manufacture to the point of use.

What is the Responsible Person in distribution?

The Responsible Person is the named, qualified individual accountable for a wholesale distribution operation under GDP. They ensure the quality system is maintained, GDP is followed, licensing conditions are met, and product is properly handled and released for onward distribution. A GDP operation cannot run effectively without one in place.

How is cold-chain integrity judged?

Cold-chain integrity is judged against the product’s labelled storage conditions. Temperature excursions are assessed using mean kinetic temperature (MKT), which weights the effect of temperature over time, to decide whether product remains within its labelled condition. Storage and shipping lanes are qualified and continuously monitored, and every handoff must preserve the traceability chain.